AMERIPRISE FINANCIAL INC - ITEOS THERAPEUTICS INC ownership

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ITEOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,458,748
-17.4%
133,219
-0.2%
0.00%
-100.0%
Q2 2023$1,766,665
-6.4%
133,434
-3.8%
0.00%0.0%
Q1 2023$1,886,890
-20.8%
138,640
+13.7%
0.00%0.0%
Q4 2022$2,383,000
-58.1%
121,987
-59.1%
0.00%
-50.0%
Q3 2022$5,683,000
+191.6%
298,333
+215.4%
0.00%
+100.0%
Q2 2022$1,949,000
-32.2%
94,584
+5.9%
0.00%0.0%
Q1 2022$2,874,00089,2990.00%
Other shareholders
ITEOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 2,738,785$37,274,86415.53%
MPM BioImpact LLC 1,745,943$23,762,2846.17%
Saturn V Capital Management LP 480,653$6,541,6874.89%
Boxer Capital, LLC 2,154,058$29,3171.44%
RA Capital Management 4,417,259$60,118,8951.36%
Octagon Capital Advisors LP 596,000$8,111,5601.17%
BVF INC/IL 1,810,835$24,645,4640.90%
AlphaCentric Advisors LLC 63,000$857,4300.59%
Integral Health Asset Management, LLC 180,000$2,449,8000.49%
683 Capital Management, LLC 480,000$6,532,8000.49%
View complete list of ITEOS THERAPEUTICS INC shareholders